Literature DB >> 1148820

Use of the Pulfrich pendulum for detecting abnormal delay in the visual pathway in multiple sclerosis.

D Rushton.   

Abstract

(1) Pulfrich's pendulum has been developed as a method for detecting abnormal delay in the visual pathway of patients with suspected multiple sclerosis. (2) Forty-one normal subjects gave a mean interocular latency difference of 2-4 +/- 1-8 msec on Pulfrich's pendulum. This mean +2 SD (6 msec) was taken as the limit of normal interocular latency difference by this method. (3) The test was assessed on 58 patients. Eighteen of these had definite multiple sclerosis, 9 had probable multiple sclerosis, and 8 had possible multiple sclerosis, according to clinical criteria. The remaining 23 patients did not conform with clinical criteria for multiple sclerosis, and served as neurological controls. Thirteen of these 23 patients had abnormal signs in the visual system. All the 58 patients also had visual evoked responses (VERs) recorded. (4) Interocular latency difference was outside the normal range in 9/18 with definite multiple sclerosis, in 3/9 with probably multiple sclerosis and in 2/8 with possible multiple sclerosis. (5) Interocular latency difference was outside the normal range in 2/23 patients with other neurological disorders. (6) There was a strong correlation between abnormality on the Pulfrich pendulum and on the VER for the multiple sclerosis group. (7) Individual results are compared with those from the VER. There was no significant correlation of the size and direction of the interocular latency difference obtained from the Pulfrich pendulum with that obtained from the VER, for any group. Possible reasons for this are discussed. (8) It is concluded that Pulfrich's pendulum is an easily performed and potentially useful subjective test for detecting abnormal dealy in the visual pathway in multiple sclerosis.

Entities:  

Mesh:

Year:  1975        PMID: 1148820     DOI: 10.1093/brain/98.2.283

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  16 in total

Review 1.  The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system.

Authors:  W I McDonald; D Barnes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-09       Impact factor: 10.154

2.  The stroboscopic Pulfrich effect is not evidence for the joint encoding of motion and depth.

Authors:  Jenny C A Read; Bruce G Cumming
Journal:  J Vis       Date:  2005-05-17       Impact factor: 2.240

3.  Influence of the Pulfrich phenomenon on driving performance.

Authors:  Armin Breyer; Xiaoyi Jiang; Adrian Rütsche; Hanspeter Bieri; Thomas Oexl; Ann Baumann; Daniel S Mojon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

4.  An unusual presentation of optic neuritis and the Pulfrich phenomenon.

Authors:  M O'Doherty; D I Flitcroft
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08       Impact factor: 10.154

5.  Measurement of interocular delays with dynamic random-dot stereograms.

Authors:  R R Diehl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 6.  The Pulfrich effect in the clinic.

Authors:  Sijie Heng; Gordon N Dutton
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-19       Impact factor: 3.117

7.  The Pulfrich phenomenon and its alleviation with a neutral density filter.

Authors:  G Heron; G N Dutton
Journal:  Br J Ophthalmol       Date:  1989-12       Impact factor: 4.638

8.  Exposure times for colour discrimination in the parafoveal field: a new procedure to detect subtle visual dysfunction in multiple sclerosis patients.

Authors:  R Menabue; P Nichelli; S Bellei
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-04       Impact factor: 10.154

9.  Foveal interocular time thresholds and latency differences in multiple sclerosis.

Authors:  W H Ehrenstein; K Manny; G Oepen
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

10.  Visual field abnormalities in multiple sclerosis.

Authors:  V H Patterson; J R Heron
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.